Early signs indicate coronavirus vaccine is effective
An interim analysis of study data from a coronavirus vaccine being developed by Pfizer and BioNTech indicates that the vaccine is highly effective in preventing COVID-19. Researchers and volunteers in Rochester have been involved in the testing of the vaccine since May, when the first human studies were launched, and technologies used in the development of the vaccine can trace their origins to decades of infectious disease research conducted at the University of Rochester Medical Center.
‘Organ on a chip’ is the wave of the future
Rochester researchers are building technology to predict the course of tendon injuries—a form of personalized medicine that will lead to more effective treatments.
Building a quantum network one node at a time
New research demonstrates a way to use quantum properties of light to transmit information, a key step on the path to the next generation of computing and communications systems.
University expands access to OMEGA EP laser with Energy Department’s LaserNetUS initiative
The Department of Energy funding, distributed to the Laser Lab and other LaserNetUS institutions, will provide beamtime for researchers across the globe to conduct laser experiments using network facilities.
Finally, a way to see molecules ‘wobble’
Breakthrough by international optics team reveals how proteins behave in 3D, enabling new insights into cell behavior and disease progression
Quantum engines? Entanglement as fuel?
It’s still more science fiction than science fact, but perfect energy efficiency may be one step closer due to new research by Rochester physicists.
Harvey Alter’s Nobel Prize honors a half-century quest
Nobel laureate Harvey Alter’s work as an NIH hematologist led to profound improvements in blood transfusion safety and starkly reduced transmission of a potentially deadly virus.
Imaging the secret lives of immune cells in the eye
Rochester researchers combine videography and artificial intelligence to track the interactions of microscopic immune cells in a living eye without dyes or damage, a first for imaging science.
Rochester graduate awarded 2020 Nobel Prize for ‘landmark achievement’ against hepatitis
NIH scientist Harvey Alter, who holds BA and MD degrees from Rochester, is the 13th Nobel laureate with ties to the University.
A route to better antibiotics: understanding ‘stressed bacteria’
Rochester biologist Anne S. Meyer’s research into the mechanisms behind bacteria’s responses may lead to more effective antibiotics and less antibiotic resistance.